M&A Deal Summary |
|
|---|---|
| Date | 2025-02-19 |
| Target | Atto-Tec |
| Sector | Medical Products |
| Buyer(s) | Leica Microsystems |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Test/Measurement Equipment |
| Revenue | 450M EUR (2006) |
Leica Microsystems GmbH is a global designer and producer of high- precision optical systems for the analysis of microstructures. It is a market leader in microscopy, pathology diagnostics, surgical microscopes as well as semiconductor wafer defect and inspection solutions and specialized electron-beam lithography systems. The company manufactures a broad range of products for numerous applications that require either microscopic visual presentation, measurement, analysis or electron-beam lithography. Leica Microsystems is represented in over 100 countries with 10 manufacturing facilities located in Europe, China and Singapore, sales and service organizations in 19 countries and an international dealer network. Leica Microsystems GmbH is based in Wetzlar, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| Country: Germany M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-06-01 |
Bioptigen
Morrisville, North Carolina, United States Bioptigen, Inc. is a technology provider in the field of optical coherence tomography (OCT). Bioptigen develops and manufactures OCT systems and software and is globally successful with products for clinical as well as translational research applications. Bioptigen, Inc. was formed in 2004 and is based in Morrisville, North Carolina. |
Buy | - |
